Suchergebnisse - "Collins, Ian"

PubPharm (367)

1

Erratum : iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells

enthalten in: iScience | 2024

von Bouguenina, H. | Nicolaou, S. | Bihan, Y. | +22

ErratumFor: iScience. 2023 Jun 07;26(7):107059. - PMID 37360684

2

PROCESS FOR MANUFACTURING 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)- 2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE

enthalten in: Europäisches Patentamt | 2024

von COLLINS IAN | MATTHEWS THOMAS PETER | FARIA DA FONSECA MCHARDY TATIANA | +4

3

SUBSTITUTED BICYCLES AS HSET INHIBITORS

enthalten in: Europäisches Patentamt | 2024

von BUCHSTALLER HANS-PETER | KUHN DANIEL | COLLINS IAN | +4

4

5-[[4-[[-2-]]-5--2-]]-2- 5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-TRIFLUOROMETHYL-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

enthalten in: Europäisches Patentamt | 2024

von COLLINS IAN | MATTHEWS THOMAS PETER | FARIA DA FONSECA MCHARDY TATIANA | +4

5

Telehealth in oncology : a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial

enthalten in: Internal medicine journal | 2023

von Alexander, M. | Collins, I. | Abraham, P. | +7

6

A Degron Blocking Strategy Towards Improved CRL4CRBN Recruiting PROTAC Selectivity

enthalten in: Chembiochem : a European journal of chemical biology | 2023

von Bouguenina, H. | Scarpino, A. | O'Hanlon, J. | +19

7

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof

enthalten in: Europäisches Patentamt | 2023

von COLLINS IAN | MATTHEWS THOMAS PETER | MCHARDY TATIANA FARIA DA FONSECA | +4

8

5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof

enthalten in: Europäisches Patentamt | 2023

von COLLINS IAN | MATTHEWS THOMAS PETER | MCHARDY TATIANA FARIA DA FONSECA | +4

9

Determination of Ligand-Binding Affinity (Kd) Using Transverse Relaxation Rate (R2) in the Ligand-Observed 1H NMR Experiment and Applications to Fragment-Based Drug Discovery

enthalten in: Journal of medicinal chemistry | 2023

von Liu, M. | Mirza, A. | McAndrew, P. | +14

10

iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells

enthalten in: iScience | 2023

von Bouguenina, H. | Nicolaou, S. | Le Bihan, Y. | +22

ErratumIn: iScience. 2024 Apr 14;27(5):109727. - PMID 38646177

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]